1. Home
  2. NTRA vs HAL Comparison

NTRA vs HAL Comparison

Compare NTRA & HAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • HAL
  • Stock Information
  • Founded
  • NTRA 2003
  • HAL 1919
  • Country
  • NTRA United States
  • HAL United States
  • Employees
  • NTRA N/A
  • HAL N/A
  • Industry
  • NTRA Medical Specialities
  • HAL Oilfield Services/Equipment
  • Sector
  • NTRA Health Care
  • HAL Energy
  • Exchange
  • NTRA Nasdaq
  • HAL Nasdaq
  • Market Cap
  • NTRA 21.5B
  • HAL 17.9B
  • IPO Year
  • NTRA 2015
  • HAL N/A
  • Fundamental
  • Price
  • NTRA $160.50
  • HAL $21.26
  • Analyst Decision
  • NTRA Strong Buy
  • HAL Strong Buy
  • Analyst Count
  • NTRA 16
  • HAL 18
  • Target Price
  • NTRA $185.56
  • HAL $33.17
  • AVG Volume (30 Days)
  • NTRA 1.3M
  • HAL 15.6M
  • Earning Date
  • NTRA 08-07-2025
  • HAL 07-22-2025
  • Dividend Yield
  • NTRA N/A
  • HAL 3.21%
  • EPS Growth
  • NTRA N/A
  • HAL N/A
  • EPS
  • NTRA N/A
  • HAL 2.40
  • Revenue
  • NTRA $1,831,000,000.00
  • HAL $22,557,000,000.00
  • Revenue This Year
  • NTRA $19.92
  • HAL N/A
  • Revenue Next Year
  • NTRA $16.02
  • HAL $0.92
  • P/E Ratio
  • NTRA N/A
  • HAL $8.85
  • Revenue Growth
  • NTRA 51.50
  • HAL N/A
  • 52 Week Low
  • NTRA $92.14
  • HAL $18.72
  • 52 Week High
  • NTRA $183.00
  • HAL $37.08
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 54.70
  • HAL 41.62
  • Support Level
  • NTRA $159.50
  • HAL $20.16
  • Resistance Level
  • NTRA $170.48
  • HAL $20.85
  • Average True Range (ATR)
  • NTRA 4.85
  • HAL 0.69
  • MACD
  • NTRA -0.50
  • HAL -0.20
  • Stochastic Oscillator
  • NTRA 56.94
  • HAL 2.50

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About HAL Halliburton Company

Halliburton is North America's largest oilfield service company as measured by market share. Despite industry fragmentation, it holds a leading position in the hydraulic fracturing and completions market, which makes up nearly half of its revenue. It also holds strong positions in other service offerings like drilling and completions fluids, which leverages its expertise in material science, as well as the directional drilling market. While we consider SLB the global leader in reservoir evaluation, we think Halliburton leads in any activity from the reservoir to the wellbore. The firm's innovations have helped multiple producers lower their development costs per barrel of oil equivalent, with techniques that have been homed in over a century of operations.

Share on Social Networks: